This is the authors' abstract. We don't add key points for this paper.
Congenital intracranial hemangiomas are rare benign vascular tumors that develop before birth. Although various treatments, including surgery, steroids, interferon-α, thalidomide, bevacizumab, or propranolol, have been reported, no standard therapy has been established. We report the case of a neonate with congenital intracranial hemangioma and central nervous system symptoms requiring therapeutic intervention. Early postnatal oral propranolol treatment was safe and effective. The neurological prognosis is good post-treatment; however, follow-up is needed to determine the long-term neurological prognosis.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: